Atlas Trials

Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation

Clinical trial NCT07725432 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07725432
Sponsor
University of Zurich
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Immune-related Vitiligo-like-Depigmentation
Start date
2024-07-25
Primary completion
2026-07-07
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.